Eurotimes, the official magazine of the European Society of Cataract and Refractive Surgeons, recently interviewed Dr. Emilio Torres-Netto of the ELZA Institute in Zurich, Switzerland, about the preliminary results from a Phase III clinical trial of photo-activated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) for the treatment of infectious corneal infiltrates and early corneal ulcers.
This study was is led by the http://www.elza-institute.com/de-ch/ in Zurich, Switzerland and conducted jointly with the Centre for Applied Biotechnology and Molecular Medicine at the University of Zurich (Zurich, Switzerland), the Narayana Nethralaya Eye Hospital (Bangalore, India), the Ben-Gurion University of the Negev Sheva (Beer-Sheva, Israel) and the Wenzhou Medical University (Wenzhou, China).
